about
Autoimmune-like drug-induced liver injury: a review and update for the clinician.Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.Autoimmune hepatitis triggered by nitrofurantoin: a case series.Factors affecting drug-induced liver injury: antithyroid drugs as instances.Current status of therapy in autoimmune liver diseaseRecurrent acute hepatitis associated with use of cetirizine.Tracing environmental markers of autoimmunity: introducing the infectome.Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice.Hepatic cytochrome P450 degradation: mechanistic diversity of the cellular sanitation brigade.The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity.Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis.Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment methodClinical perspectives on xenobiotic-induced hepatotoxicity.Acute exacerbation of autoimmune hepatitis induced by Twinrix.The X and why of xenobiotics in primary biliary cirrhosisA neuropsychiatrist's perspective on selected dermatoses.Acute respiratory distress syndrome and hepatotoxicity associated with single dose nitrofurantoin useMechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications.Drug-Induced Liver Injury Associated with Noni (Morinda citrifolia) Juice and Phenobarbital.Investigations toward enhanced understanding of hepatic idiosyncratic drug reactions.Drug-induced splenic enlargement.Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury.Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicinesAnalysis of liver function test abnormalities in kidney transplant recipients: 7 year experience.Black Cohosh Hepatotoxicity with Autoimmune Hepatitis Presentation.Drug-induced autoimmune-like hepatitis.Idiosyncratic drug-induced liver injury: an update on the 2007 overview.Female gender as a susceptibility factor for drug-induced liver injury.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes.Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis.Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment.The role of intrahepatic CD3+/CD4-/CD8- double negative T (DN T) cells in enhanced acetaminophen toxicity.Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury.Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.Autoimmune hepatitis unmasked by nimesulide.Nonionic surfactant based thymoquinone loaded nanoproniosomal formulation: in vitro physicochemical evaluation and in vivo hepatoprotective efficacy.Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients.
P2860
Q30276377-8BC6991F-8A18-4463-812A-3ECD31A1D600Q33563872-6216614D-73CA-4DFE-BD00-EE24C6935DA7Q34199672-D7843D5B-1618-4A58-8B25-712A99D4F015Q34339590-032B95C1-2AF7-4270-96CF-66EE8BDA21BFQ34408950-64E79F70-177E-4F08-AFEE-050A2CA7C6E5Q34551111-36C62B87-C797-4FEF-AABD-53AC9DCA0EFEQ34671373-706F6617-C82D-4421-B542-BDA13068A003Q35080126-1E2F553E-2D54-44A2-BD34-39FAA44888F3Q35213373-E668105D-B57E-4A3B-BE1A-EA493A16F941Q35341829-F17BE33D-69E1-40F6-8051-D5036D08ACA1Q35490308-638B1514-ACB8-48CA-932F-289DE598EFC2Q35507135-8E2C89BC-B128-4A28-B6AC-09E38619CBF3Q35644300-12D47BD9-AC79-4DD4-977A-E6FF11EDD01DQ35828028-69BCF096-8B92-4E3D-8B6E-505D8882E071Q35851196-B47A4D87-0AF2-4694-B486-3CC47DC7164AQ35916081-4A4EFDD6-BB9D-45E6-A4A5-0F1A14CE2620Q36363603-BDE6E5DC-D915-4267-9F24-2910E4FD4AF8Q36446675-0F78499C-54FD-47C4-902B-9F9411C2CEB5Q36479455-26FA8711-3419-4404-9319-483C3C81027FQ36613769-8BA581C4-E8FD-401A-B89E-B22B4535B41EQ36662857-84CE1876-7273-48FE-823F-99E72F868E48Q36762455-3CF39DD9-A7AC-43EE-9A4F-B961BCAAD67AQ37038993-4848654F-376B-44E2-A7D7-2D7DBD90CD64Q37229883-A9903934-E7AF-467A-84FB-358AF6B8694FQ37563064-F4132044-CE31-4E92-98D4-591C00F4655DQ37634909-3478900E-D4F4-466F-A9E4-CFB6E247AA15Q37843783-401AD1ED-F780-4B0B-A6CF-DF87EE0817ABQ38145274-3771AB11-AB5F-4DB8-ADD8-00544B14121DQ38168331-5AF1EEE8-AEDA-4330-91E2-0B8482FDAF14Q38496935-BC021281-CB6F-4553-9928-AB68ED5597B8Q38758672-387E4897-3BBA-4832-825B-60DD7FA55893Q40995506-FB8E2F80-E589-4606-9702-C34873490A3EQ41355985-99399D35-0FF4-4568-ABB6-77ECE835EE20Q42704352-0F141699-7EB4-44D5-9298-6BB6C2F5CAFDQ43050091-54ADB1EB-98FC-4C14-A57B-4B8FB251187AQ43434328-BF9A5434-3397-414B-A436-3FFC5B54B303Q47869967-1E4785AB-35D5-4C4D-8641-7746BF4108ACQ48257999-423B5235-E7D9-432A-A6D7-5928C4CA0B98Q48285216-FEB3B983-5F52-4859-A6CD-7D8182C0420FQ52597721-61639269-C255-45AC-89ED-7421C3F30A10
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immune-mediated drug-induced liver disease.
@ast
Immune-mediated drug-induced liver disease.
@en
Immune-mediated drug-induced liver disease.
@nl
type
label
Immune-mediated drug-induced liver disease.
@ast
Immune-mediated drug-induced liver disease.
@en
Immune-mediated drug-induced liver disease.
@nl
prefLabel
Immune-mediated drug-induced liver disease.
@ast
Immune-mediated drug-induced liver disease.
@en
Immune-mediated drug-induced liver disease.
@nl
P1476
Immune-mediated drug-induced liver disease.
@en
P2093
Neil Kaplowitz
Zhang-Xu Liu
P304
P356
10.1016/S1089-3261(02)00025-9
P577
2002-08-01T00:00:00Z